Skip to content
In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation.
Watch the full FDA listening session in the video below.
Posted on October 15, 2020
Prev: The Overview: October 2020
Next: Focusing on the Next Line of Defense Against Ovarian Cancer | Meet a Scientist